Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Smiles: CN1CCN(CC1)C1C=CC(=CC=1)NC1=NC(=CC=N1)N(C1=CC=C(C=C1OC)OC)C(=O)OC1=CC(=CC=C1C)C(=O)NC1=CC(=CC=C1)C(F)(F)F
both basal and IGF stimulated Akt1 and Akt2 phosphorylation are inhibited in mouse lung
Infliximab ameliorates TNF-α-induced insulin resistance in 3T3L1 adipocytes in vitro by restoring the insulin signalling pathway via PTP1B inhibition
The glucagon-stimulated increases in the level of Ca2+ can be mimicked by Sp-cAMPS
(R)-Pirtobrutinib Size:Contact [email protected] for quotation Smiles: CN1CCN(CC1)C1C=CC(=CC=1)NC1=NC(=CC=N1)N(C1=CC=C(C=C1OC)OC)C(=O)OC1=CC(=CC=C1C)C(=O)NC1=CC(=CC=C1)C(F)(F)F(R) Pirtobrutinib ((R) LOXO 305) is a less active enantiomer of Pirtobrutinib. Pirtobrutinib (LOXO 305), a highly selective and non covalent next generation BTK inhibitor, inhibits diverse BTK C481 substitution mutations. Product information CAS Number: 2101700 14 3 Molecular Weight: 479. 43 Formula: C22H21F4N5O3 Chemical Name: (R) 5 amino 3 (4 ((5 fluoro 2 methoxybenzamido)methyl)phenyl) 1 (1, 1, 1 trifluoropropan 2 yl) 1H pyrazole 4 carboxamide
US$ 52.00
US$ 2182.00
US$ 1625.00
US$ 1975.00
US$ 14.99
US$ 1625.00
US$ 1625.00
US$ 146.00